Open access
Open access
Powered by Google Translator Translator

Cardiology (all articles)

Review: Mechanical complications of acute myocardial infarction

11 Dec, 2020 | 09:19h | UTC

Mechanical Complications of Acute Myocardial Infarction: A Review – JAMA Cardiology

Videos: Acute Rupture of Left Ventricular Aneurysm AND Ventricular Septal Rupture AND Papillary Muscle Rupture

 


Global burden of cardiovascular diseases and risk factors, 1990–2019

10 Dec, 2020 | 09:00h | UTC

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study – Journal of the American College of Cardiology

News Release: JACC: Cardiovascular Disease Burden, Deaths Are Rising Around the World – Institute for Health Metrics and Evaluation

 

Commentary on Twitter

 


A nationwide study in Denmark showed a higher than expected risk of cardiac events in patients with cancer receiving immune checkpoint inhibitors

10 Dec, 2020 | 08:49h | UTC

The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study – European Heart Journal

Commentary: Cancer patients receiving immunotherapy drugs have a higher risk of heart problems – European Society of Cardiology

 


Review: Cardiopulmonary impact of particulate air pollution in high-risk populations

9 Dec, 2020 | 08:07h | UTC

Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations: JACC State-of-the-Art Review – Journal of the American College of Cardiology

Commentary: Air Pollution a Public Health Threat; Strategies to Reduce Exposure Needed, JACC Review Paper Says – American College of Cardiology

 


Cohort study: In the general population, both low and high levels of LDL cholesterol were associated with an increased risk of all-cause mortality

9 Dec, 2020 | 08:11h | UTC

Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study – The BMJ

 

Commentary on Twitter

 


Observational study: Even low dose oral glucocorticoids linked to increased cardiovascular risk in people with immune-mediated inflammatory diseases

8 Dec, 2020 | 07:35h | UTC

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study – PLOS Medicine

Commentary: Patients receiving low dose steroid at increased risk of cardiovascular disease – Public Library of Science

 


Spironolactone use is associated with improved outcomes in patients with heart failure with preserved ejection fraction and concomitant resistant hypertension

8 Dec, 2020 | 07:44h | UTC

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension – Journal of the American Heart Association

Commentary: Spironolactone use associated with improved outcomes for patients with HFpEF and resistant hypertension – 2 Minute Medicine

 


Randomized trial: High-dose influenza vaccine shows no additional benefit for heart disease patients

7 Dec, 2020 | 00:44h | UTC

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial – JAMA

Editorial: Influenza Vaccine for Patients With High-risk Cardiovascular Disease

Commentary: High-dose influenza vaccine shows no additional benefit for heart disease patients – NIH News Releases

 

Commentary on Twitter

 


Meta-analysis reinforces the safety of betablockers in patients with COPD and cardiovascular disease

6 Dec, 2020 | 23:30h | UTC

Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis – European Heart Journal

Commentary: Beta-Blockers in Patients With COPD and CVD – American College of Cardiology

 


Short review: How to diagnose and manage radiation therapy cardiotoxicity

6 Dec, 2020 | 23:27h | UTC

How to Diagnose and Manage Radiation Cardiotoxicity – JACC: CardioOncology

 


Meta-analysis of statins for primary prevention: 100 adults (aged 50-75 years) without known cardiovascular disease would have to be treated for 2.5 years to prevent 1 major adverse cardiovascular event

30 Nov, 2020 | 00:56h | UTC

Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis – JAMA Internal Medicine (link to abstract – $ for full-text)

Commentary: Time to Benefit of Statins for Primary Prevention of Cardiovascular Events – American College of Cardiology

 

Commentary on Twitter

 


Practice recommendations for the management of the most common forms of secondary hypertension, including primary aldosteronism, renovascular hypertension, pheochromocytoma, Cushing’s syndrome, and sleep apnea

26 Nov, 2020 | 08:59h | UTC

Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension – High Blood Pressure & Cardiovascular Prevention

 


Cohort study suggests there is no need to choose first-line drug treatment for hypertension according to age and ethnicity – guidelines could be simplified

26 Nov, 2020 | 08:56h | UTC

First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care – The BMJ

Commentary: Study questions blood pressure drug guidance based on age and ethnicity – British Medical Journal AND Laurie Tomlinson: Shining a light into medicine’s dusty corners – The BMJ Opinion AND UK’s NICE Guidelines for Hypertension Tx Based on Age, Ethnicity May Need Updating – Physician’s Weekly AND

 

Commentary on Twitter

 


2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

23 Nov, 2020 | 09:46h | UTC

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines – Journal of the American College of Cardiology

Executive summary: 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines – Journal of the American College of Cardiology

Key perspectives: 2020 AHA/ACC Guideline for Hypertrophic Cardiomyopathy

News release: Hypertrophic cardiomyopathy guideline encourages shared decision-making – American College of Cardiology

 


Opinion: Improving care for heart failure with reduced ejection fraction—a potential polypill-based strategy

20 Nov, 2020 | 08:37h | UTC

Improving Care for Heart Failure With Reduced Ejection Fraction—A Potential Polypill-Based Strategy – JAMA

 


#AHA20 [not published yet] Randomized trial: After drug-eluting stent implantation, one-month dual antiplatelet therapy (DAPT) followed by aspirin monotherapy was noninferior to 6-12 months of DAPT

19 Nov, 2020 | 09:21h | UTC

One-Month Dual Antiplatelet Therapy Followed by Aspirin Monotherapy After Drug-Eluting Stent Implantation – One-Month DAPT – American College of Cardiology

Commentary: Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT – TCTMD

 


NICE Guideline: Acute coronary syndromes

19 Nov, 2020 | 09:24h | UTC

Acute coronary syndromes – National Institute for Health and Care Excellence

Visual summary: STEMI

Visual summary: NSTEMI/unstable angina

Visual summary: Cardiac rehabilitation and secondary prevention

 


#AHA20 – Two studies show lower rate of atrial fibrillation recurrence with catheter cryoballoon ablation than with antiarrhythmic drug therapy

18 Nov, 2020 | 09:11h | UTC

Study 1: Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation – New England Journal of Medicine

Study 2: Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation – New England Journal of Medicine

Commentaries: EARLY AF and STOP AF Put Electrophysiology at a Crossroads – Medscape (free registration required) AND EARLY-AF: First-line Ablation Beats Meds for Recent Paroxysmal A-fib – TCTMD

 

Commentary on Twitter (thread – click for more)


#AHA20 – Randomized trial: Among patients with recurrent pericarditis, Rilonacept was associated with lower risk of pericarditis recurrence than placebo

18 Nov, 2020 | 09:04h | UTC

Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Rilonacept Prevents Recurrent Pericarditis: RHAPSODY – TCTMD AND Rilonacept inHibition of interleukin-1 Alpha and beta for recurrent Pericarditis: a pivotal Symptomatology and Outcomes stuDY – RHAPSODY – American College of Cardiology AND Trial shows drug effective in 96% of patients with recurrent pericarditis – Cleveland Clinic

 

Commentary on Twitter

 


#AHA20 – RCT: Sotagliflozin improved cardiovascular outcomes in patients with Diabetes and CKD. Diarrhea, genital mycotic infections, volume depletion, and diabetic ketoacidosis were more common with sotagliflozin than with placebo

18 Nov, 2020 | 09:08h | UTC

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk – SCORED – American College of Cardiology

 


#AHA20 – RCT: Sotagliflozin improved cardiovascular outcomes in patients with Diabetes and Recent Worsening Heart Failure. Diarrhea and severe hypoglycemia were more common with sotagliflozin than with placebo

18 Nov, 2020 | 09:06h | UTC

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure – SOLOIST-WHF – American College of Cardiology

 


The ‘Ten Commandments’ for the 2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease

18 Nov, 2020 | 09:03h | UTC

The ‘Ten Commandments’ for the 2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease – European Heart Journal

Original Guideline and commentary: 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease

 


Opinion: A new important study supports wider use of the polypill

18 Nov, 2020 | 09:01h | UTC

Richard Smith: A new important study supports wider use of the polypill – The Lancet

Original study and commentaries: Randomized trial: A polypill comprising statins, multiple blood pressure lowering drugs, and aspirin prevents cardiovascular events among patients at intermediate cardiovascular risk

 

Commentary on Twitter

 


#AHA20 – Randomized trial: In patients with atrial fibrillation and a bioprosthetic mitral valve, Rivaroxaban (20 mg) was noninferior to Warfarin (INR 2-3) for death, MACE, or major bleeding at 12 months

16 Nov, 2020 | 02:01h | UTC

Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Rivaroxaban may be as effective as warfarin for bioprosthetic mitral valves, AF – American Heart Association

Commentaries: Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib – TCTMD AND Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation – RIVER – American College of Cardiology AND Rivaroxaban Noninferior to Warfarin for Atrial Fibrillation in Patients with Bioprosthetic Mitral Valves – NEJM Journal Watch

 

Commentary on Twitter

 


#AHA20 – Randomized trial: A polypill comprising statins, multiple blood pressure lowering drugs, and aspirin prevents cardiovascular events among patients at intermediate cardiovascular risk

16 Nov, 2020 | 02:03h | UTC

Polypill with or without Aspirin in Persons without Cardiovascular Disease – New England Journal of Medicine (link to abstract – $ for full-text)

News release: New study confirms combo pill alone and with aspirin lowers heart disease risk – American Heart Association

Commentaries: Polypill along with aspirin cuts heart attacks and strokes by up to 40%: International study – McMaster University AND Big study supports cheap combo pill to lower heart risks – Associated Press AND TIPS-3: International Study Looks at Benefits of Polypill and Polypill Plus Aspirin in Reducing CVD Risk – American College of Cardiology

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.